|
US2013237505A1
|
|
Topical compositions for treatment of skin conditions
|
|
US6596734B1
|
|
Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
|
|
US6593341B2
|
|
β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
|
|
CA2393788A1
|
|
.beta.3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
|
|
WO0174782A1
|
|
β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
|
|
EP1023269A1
|
|
Beta3-adrenoreceptor agonists, agonist compositions and methods of using
|
|
WO9732839A1
|
|
9-cis-retinoic acid esters and amides and uses thereof
|
|
US5837728A
|
|
9-cis retinoic acid esters and amides and uses thereof
|
|
USRE34075E
|
|
Dermal uses of trans-retinoids for the treatment of cancer
|
|
US5124356A
|
|
Dermal uses of trans-retinoids for the treatment of photoaging
|
|
US5049584A
|
|
Dermal uses of cis-retinoids for the treatment of cancer
|
|
US4994491A
|
|
Dermal uses of trans-retinoids for the treatment of cancer
|
|
US4885311A
|
|
Topical transretinoids for treatment of acne and skin diseases
|
|
AU7543287A
|
|
Topical prodrugs for treatment of acne and skin diseases
|
|
US4677120A
|
|
Topical prodrugs for treatment of acne and skin diseases
|
